22 related articles for article (PubMed ID: 2508995)
1. Improved synthesis of deoxyalpinoid B and quantification of antileishmanial activity of deoxyalpinoid B and sulforaphane.
Leary E; Anderson ET; Keyes JK; Huskie TR; Blake DJ; Miller KA
Bioorg Med Chem; 2023 Jan; 78():117136. PubMed ID: 36565668
[TBL] [Abstract][Full Text] [Related]
2. Synthetic studies of nucleoside antibiotics: a formal synthesis of (+)-sinefungin.
Ghosh AK; Wang Y
J Chem Soc Perkin 1; 1999; 1999(24):3597-3601. PubMed ID: 30344366
[TBL] [Abstract][Full Text] [Related]
3. Trifluralin liposomal formulations active against Leishmania donovani infections.
Carvalheiro M; Jorge J; Eleutério C; Pinhal AF; Sousa AC; Morais JG; Cruz ME
Eur J Pharm Biopharm; 2009 Feb; 71(2):292-6. PubMed ID: 18761404
[TBL] [Abstract][Full Text] [Related]
4. Potential of doxorubicin as an antileishmanial agent.
Sett R; Basu N; Ghosh AK; Das PK
J Parasitol; 1992 Apr; 78(2):350-4. PubMed ID: 1556650
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo antileishmanial efficacy of a new nitrilquinoline against Leishmania donovani.
Nakayama H; Desrivot J; Bories C; Franck X; Figadère B; Hocquemiller R; Fournet A; Loiseau PM
Biomed Pharmacother; 2007; 61(2-3):186-8. PubMed ID: 17360145
[TBL] [Abstract][Full Text] [Related]
6. Antileishmanial effect of cisplatin against murine visceral leishmaniasis.
Kaur S; Sachdeva H; Dhuria S; Sharma M; Kaur T
Parasitol Int; 2010 Mar; 59(1):62-9. PubMed ID: 19853668
[TBL] [Abstract][Full Text] [Related]
7. Combination therapy using sodium antimony gluconate in stearylamine-bearing liposomes against established and chronic Leishmania donovani infection in BALB/c Mice.
Pal S; Ravindran R; Ali N
Antimicrob Agents Chemother; 2004 Sep; 48(9):3591-3. PubMed ID: 15328135
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of visceral leishmaniasis: efficacy and limits of miltefosine].
Gangneux JP; Marty P
Sante; 2001; 11(4):257-8. PubMed ID: 11861203
[No Abstract] [Full Text] [Related]
9. Engima of therapeutic failure in visceral leishmaniasis.
Arya SC
J Assoc Physicians India; 1993 Mar; 41(3):155-8. PubMed ID: 8226600
[No Abstract] [Full Text] [Related]
10. Visceral leishmaniasis: Revisiting current treatments and approaches for future discoveries.
No JH
Acta Trop; 2016 Mar; 155():113-23. PubMed ID: 26748356
[TBL] [Abstract][Full Text] [Related]
11. Antileishmanial effect of free and encapsulated sinefungin against Leishmania donovani infections in BALB/c mice.
Neal RA; Iwobi MV; Robert-Gero M
C R Acad Sci III; 1989; 308(18):485-8. PubMed ID: 2508995
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
